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Abstract
Microbial culture collections underpin biotechnology applications and are important resources for
clinical microbiology by supplying reference strains and/or performing microbial identifications as a
service. Proteomic profiles by MALDI-TOF MS have been used for Candida spp. identification in
clinical laboratories and demonstrated to be a fast and reliable technique for the routine identification
of pathogenic yeasts. The main aim of this study was to apply MALDI-TOF MS combined with clas-
sical phenotypic and molecular approaches to identify Candida clinical isolates preserved from 1 up
to 52 years in a Brazilian culture collection and assess its value for the identification of yeasts pre-
served in this type of collections. Forty Candida spp. clinical isolates were identified by morphologi-
cal and biochemical analyses. Identifications were also performed by the new proteomic approach
based on MALDI-TOF MS. Results demonstrated 15% discordance when compared with morpho-
logical and biochemical analyses. Discordant isolates were analysed by ITS sequencing, which con-
firmed the MALDI-TOF MS identifications and these strains were renamed in the culture collection
catalogue. In conclusion, proteomic profiles by MALDI-TOF MS represents a rapid and reliable
method for identifying clinical Candida species preserved in culture collections and may present
clear benefits when compared with the performance of existing daily routine methods applied at
health centres and hospitals.
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Introduction
Culture collections play a key role in microbiology,
since they are responsible for gathering and preserving well
characterised strains. In addition, culture collections are re-
sponsible for ex situ preservation of microbial resources
and their related information. In fact, each single microbial
strain has not great value unless it is very well characterised
with the current state of the art applied for each microbial
group and the related information available in the appropri-
ate format (Boundy-Mills, 2012).
The scientific community and the end users demand
from the culture collections authentic biological materials
with reproducible properties that allow them to use the
strains to fit their needs: as type strains for taxonomic pro-
poses, reference strains as standards, or even unique strains
for research and exploitation of their peculiar properties
(Smith, 2012; Simões et al., 2013). The current challenges
created by the OECD best practices guidelines for Biologi-
cal Resource Centres (BRCs) generated an unprecedented
wave in culture collections to adopt new practices and
methods in order to guarantee high quality operational stan-
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dards and provide authentic materials (OECD, 2007;
Schoch et al., 2012).
The historical Brazilian fungal service culture collec-
tion University Recife Mycology (URM,
www.ufpe.br/micoteca) was established by Prof. Chaves
Batista in 1954 and is hosted by the Department of Mycol-
ogy of the Federal University of Pernambuco (Recife,
Brazil). Since the number and clinical impact of severe in-
fections due to yeast species has increased the identifica-
tion of yeast species with clinical relevance is one among
several significant services offered by the URM culture
collection. In addition, the sub-set collection of Candida
species is of relevance due to possibility of supplying refer-
ence strains for clinical studies.
Candida species emerged as the major opportunistic
pathogens in immunocompromised patients, and currently
constitute one of the most common causes of nosocomial
infections in intensive care units (Marklein et al., 2009).
Currently, this genus comprises more than 160 species, is
expanding rapidly and is under a continuous taxonomic re-
vision. Approximately 20 species cause disease in humans,
although the number of new reports is increasing (Qian et
al., 2008; Putignani et al., 2011). Candidemia is the fourth
most common cause of hospital bloodstream infection
worldwide being associated with extended hospital stays
and high mortality rates among critically ill patients (Me-
drano et al., 2006). The case/fatality rate is approximately
34% with an estimated 72.8 million worldwide opportunis-
tic Candida infections per year (Marklein et al., 2009).
The time required for pathogen identification is an
important determinant in the infection-related mortality
rates in hospitalised patients. Death rates and costs associ-
ated with infectious diseases could significantly be reduced
by employing rapid identification techniques (Essendoubi
et al., 2005). Inevitably, non-Candida yeasts that can act as
human pathogens have been misidentified as Candida spe-
cies. Their identification may pose a challenge when the
type strains have not yet been included into the diagnostic
databases of any semi- or full-automated identification sys-
tem (Lockhart et al., 2008; Marklein et al., 2009; Putignani
et al., 2011). Several reports have addressed the difficulty
to identify yeast strains to the species level by conventional
methods, since they are highly dependent on variables such
as growth medium and temperature (Latouche et al., 1997;
Mozina and Raspor, 1997; Correia et al., 2006; Leaw et al.,
2006; Qian et al., 2008) and, in some limit cases, the inter-
pretation of the results remain very subjective. This makes
both molecular biology and spectral approaches crucial
when the mycologist faces an isolate with unusual traits.
Matrix Assisted Laser Desorption/Ionisation Time-
Of-Flight Mass Spectrometry (MALDI-TOF MS) is a
physic-chemical technique that has been used for rapid and
reliable microbial identification. The spectrum generated is
analysed as an individual proteomic profile with the molec-
ular mass ranging from 2000 to 20000 Da, where important
ribosomal proteins appear, which is an advantage because
they can be readily employed as biomarkers (Santos et al.,
2010a, 2011; Passarini et al., 2013). Proteomic profiles by
MALDI-TOF MS for rapid identification of intact bacteria
were firstly used in 1996 (Holland et al., 1996). More re-
cently MALDI-TOF MS has been used to detect and iden-
tify yeasts. It is able to discriminate closely related species,
such as C. glabrata from C. bracarensis, C. albicans from
C. dubliniensis and, C. metapsilosis and C. orthopsilosis
from C. parapsilosis, previously separated only by molecu-
lar methods (Sullivan et al., 1995; Tavanti et al., 2005;
Correia et al., 2006; van Veen et al., 2010; Jensen and
Arendrup, 2011; Marinach-Patrice et al., 2010; Putignani et
al., 2011; Santos et al., 2011) or Fourier Transform Infrared
(FT-IR) techniques (Santos et al., 2010b).
The purpose of the present study was to apply
MALDI-TOF MS combined with classical phenotypic and
molecular approaches to identify Candida clinical isolates
preserved from 1 up to 52 years in a Brazilian culture col-
lection and assess its value for the identification of yeasts
preserved in this type of service collections.
Materials and Methods
Strains and growth conditions
All 40 Candida isolates analysed in this study were
obtained from the URM culture collection
(www.ufpe.br/micoteca). This set of yeasts comprises all
clinical isolates of this genus available at URM. Esche-
richia coli strain DH5 was used as standard for the
MALDI-TOF MS external calibration and was obtained
from the Micoteca da Universidade do Minho (MUM,
www.micoteca.deb.uminho.pt). Trichophyton rubrum
MUM 09.09 was incorporated into the analysis as an out-
group. All cultures were preserved at -80 °C and cryovials
were thawed, opened and the strains sub-cultured accord-
ing to the instructions issued by URM and MUM culture
collections. Homogenous inocula of yeast cells were grown
and maintained on Yeast Extract Peptone Dextrose agar
medium (YEPD). Escherichia coli cells were grown and
maintained on Luria-Bertani agar medium (LB). Incuba-
tions were standardised at 20 h and strains were grown aer-
obically at 37 °C. In order to avoid changes in the protein
expression pattern the culture conditions and growth time
were standardised as described above. All cultures were
checked for purity prior to use and were sub-cultured at
least twice prior to MALDI-TOF MS analysis.
Classical phenotypic identification
The isolates were identified by macro- and micro-
morphology. The colour, shape, topology of each colony
and the cell morphology were considered using Sabouraud
dextrose agar medium with 2.5% yeast extract (Difco,
USA). The induction of sexual reproduction structure using
Gorodkowa agar (Difco, USA) was performed. Chlamy-
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dospores were induced on bile agar (Difco, USA) and
scored as present or absent after 3 days at 25 °C. The iso-
lates were tested biochemically by carbohydrate assimila-
tion and fermentation assays. The production of urease and
acetic acid were also assessed using urea and calcium car-
bonate media (Difco, USA), respectively. The maximum
temperature of growth for each isolate was determined ac-
cording Barnett et al. (2000) and De Hoog et al. (2000).
The isolates which presented ambiguous identification
were further analysed by VITEK-2 XL (bioMerieux,
Brazil) according to previous reports (Macedo et al., 2009).
MALDI-TOF MS plate preparation
Using a yellow tip a tiny sample (about 106 yeasts per
sample) was transferred directly from a single colony and
spotted onto the 48 well flex target plate (FlexiMass, Shi-
madzu Biotech, UK). Aliquots of 0.5 L of 25% formic
acid were added and mixed gently with the yeasts. When
the liquid medium was almost evaporated 0.5 L matrix so-
lution (75 mg/mL 2,5-dihydroxybenzoic acid [DHB] in
ethanol/water/acetonitrile [1:1:1; v/v/v] with 0.03% trifluo-
roacetic acid [TFA]) was added and mixed gently. The ma-
trix solution addition was performed without the additional
treatment with formic acid for E. coli. All solutions were
freshly prepared and stored at 5 °C during the work. In or-
der to assess the quality and reproducibility of the spectral
data, each yeast isolate was analysed in duplicate. All sam-
ples were air dried at room temperature and finally ana-
lysed by MALDI-TOF MS.
MALDI-TOF MS data acquisition
The analyses were performed on an Axima LNR sys-
tem (Kratos Analytical, Shimadzu, UK) equipped with a ni-
trogen laser (337 nm), where the laser intensity was set just
above the threshold for ion production. Twelve defined ri-
bosomal proteins of intact E. coli DH5 cells (4365.4,
5096.8, 5381.4, 6241.4, 6255.4, 6316.2, 6411.6, 6856.1,
7158.8, 7274.5, 7872.1, 9742 and 12227.3 Da) were used as
external calibrants of the MALDI-TOF MS equipment
(Passarini et al., 2013). The mass range from 2000 to
20000 Da was recorded using the linear mode with a delay
of 104 ns and an acceleration voltage of +20 kV. Final spec-
tra were generated by summing 20 laser shots accumulated
per profile and 50 profiles produced per sample, leading to
1000 laser shots per summed spectrum. The resulting peak
lists were exported to the database of the SARAMIS pack-
age software (Spectral Archiving and Microbial Identifica-
tion System, AnagnosTec, Germany, www.anagnostec.eu)
where the final identifications were achieved. Identifica-
tions by the SARAMIS package are based on the presence
or absence of each peak in the spectra.
MALDI-TOF MS clustering analysis
Cluster analyses of the MALDI-TOF MS spectral
data were achieved using the SARAMIS database software.
In this database peak lists of individual samples were com-
pared to matching SuperSpectra and/or reference spectra
generated by the system. For SuperSpectra and reference
spectra, SARAMIS uses a point system based on peak list
with mass signals weighed according to their specificity.
The weighting is based on empirical data from multiple
samples of type, reference and well characterised yeast
strains. SuperSpectra are consensus spectra containing a
pattern of mass signals, which are taxa-specific and allow
the identification of strains and cluster analyses of spectra
of multiple samples. In present study superspectra for C.
albicans, C. parapsilosis, C. tropicalis and P. kudriavzevii
were used. Reference spectra of C. albicans CBD 924, C.
parapsilosis CBD 1325 and C. tropicalis CBD 957 were
used as individual empiric spectra of well characterised
yeast species. In both cases, the similarity between individ-
ual spectra is expressed as a relative or an absolute number
of matching mass signals after subjecting the data to a sin-
gle link agglomerative clustering algorithm. The database
included SuperSpectra and/or reference spectra of all the
yeasts described herein.
ITS sequencing and sequence analysis
Isolates that presented distinctive identification by
the classical and new spectral phenotypic approaches were
analysed by ITS sequencing. ITS region was chosen taking
into consideration that this region is formally the primary
fungal barcode marker recommended by the Consortium
for the Barcode of Life (Schoch et al., 2012). Sequence
analysis was carried out on the entire ribosomal ITS region
(i.e., ITS1/58S rDNA/ITS2), according to White et al.
(1990). Sequencing was performed with an ABI 310 Ge-
netic Analyser (Applied Biosystems) using standard proto-
cols. Strains were identified at the level of 99.0% sequence
similarity or higher after a NCBI blast.
Results
Classical phenotypic identification
Forty yeast isolates from clinical cases were identi-
fied using classic phenotypic identification (Table 1). Iden-
tities were as follow: 20 C. albicans, 5 C. krusei, 11 C.
parapsilosis and 4 C. tropicalis. Sexual reproduction was
not observed on Gorodkowa agar although, in contrast,
chlamydospores were observed from all C. albicans iso-
lates. In order to clarify identification difficulties on iso-
lates that presented ambiguity, URM 4990, 4388, 4124,
4818, 4261 and 1150, VITEK-2 XL was used. This method
corroborated all previous phenotypic identifications for
these 6 isolates.
MALDI-TOF MS identification
Six isolates (15%) identified by MALDI-TOF MS did
not correspond to the phenotypic identification (Table 1).
The C. krusei isolates were classified as Pichia kudriavzevii
Candida isolates collection 517
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Figure 1 - MALDI-TOF spectra based dendrogram of yeast isolates evaluated in this work. Discordances obtained by MALDI-TOF MS and classical
phenotypic analyses are highlighted by grey boxes. CBD reference strains and Superspectra are marked by * and **, respectively. Trichophyton rubrum
MUM 09.09 was used as outgroup.
(former Issatchenkia orientalis) using the SARAMIS soft-
ware package, which is the basionym teleomorphic name.
Isolates URM 4261, 3627, 3624 and 3621 were iden-
tified as C. parapsilosis by phenotype. However, URM
4261 and 3624 were C. tropicalis and URM 3627 and 3621
were C. albicans by MALDI-TOF MS. Isolate URM 4261
was one of the six samples confirmed by VITEK-2 XL as
C. parapsilosis. This finding corresponds to 16.7% of dis-
cordance in the overall isolates analysed by VITEK-2 XL
in relation to the spectral phenotypic identification.
URM 4608 was identified as C. parapsilosis pheno-
typically and was recorded as “unidentified” by MALDI-
TOF MS, grouping separately on the dendrogram (Figu-
re 1). This separation was confirmed by the molecular biol-
ogy results presented below.
Finally, URM 3719 was identified as C. albicans
phenotypically and as C. tropicalis by MALDI-TOF MS.
ITS identification
All six isolates that presented discordant results from
phenotypic and MALDI-TOF MS identifications were ana-
lysed by ITS sequencing. URM 3621 and 3627 isolates
were identified as C. parapsilosis by phenotype and C.
albicans by MALDI-TOF MS (Table 1). ITS sequencing
confirmed that these clinical yeast strains were C. albicans
(URM 3627, accession nº KF031307). URM 4261 (acces-
sion nº KF031306) and 3624 (accession nº KF031304)
were confirmed as C. tropicalis by ITS sequencing.
URM 3719 was identified as C. albicans by pheno-
type but grouped with C. tropicalis by MALDI-TOF MS
(Table 1 and Figure 1), and was confirmed as C. tropicalis
by ITS analysis (accession nº KF031305).
URM 4608 that was identified as C. parapsilosis by
phenotype could not be identified by MALDI-TOF MS,
grouping separately from the C. parapsilosis cluster in the
MALDI-TOF MS dendrogram (Figure 1). However, it was
identified as C. doubushaemulonii by ITS (accession nº
KF031310) and when this new taxon information was
added to the SARAMIS database, the isolate was recorded
as C. doubushaemulonii (Figure 1).
Although the good concordance between pheno-
typical and spectral identification of Pichia kudriavzevii,
strains URM 1059 and URM 4802 were chosen for addi-
tional ITS analysis. The sequencing results confirmed their
identifications (accession nº KF031308 and KF031309, re-
spectively).
Discussion
A comparison between the discriminative capability
of phenotypic and MALDI-TOF MS characters of 40 clini-
cal yeasts was reported herein. Moreover, discordant iso-
lates were analysed by ITS sequencing which confirmed
the MALDI-TOF MS identifications. Phenotype grouped
the isolates into four distinct species: C. albicans, C. krusei
(P. kudriavzevii), C. parapsilosis and C. tropicalis. In addi-
tion, 6 out of 40 (15%) strains analysed by this method dis-
agreed with the identification performed by MALDI-TOF
MS. In line with described by Santos et al. (2011) the
MALDI-TOF MS results were confirmed strongly by the
ITS sequencing analyses. Through these combined ap-
proaches five strains were renamed and one additional spe-
cies was added to the collection: C. doubushaemulonii. The
current data, when combined with data previously de-
scribed (Marinach-Patrice et al., 2010; Jensen and Aren-
drup, 2011; Santos et al., 2011), indicate that MALDI-TOF
MS analysis is a powerful technique to identify clinical
Candida isolates.
Because ribosomal proteins can be easily used as
biomarkers in the proteomic-based technique by MALDI-
TOF MS the reliability of this methodology is high and can
discriminate between closely related Candida species.
However, due to the biological variability of these yeasts,
even for a single species, the availability of an extensive da-
tabase is required. For example, MALDI-TOF MS gener-
ated a distinctive spectrum for C. doubushaemulonii URM
4608, separating it from the other isolates in the den-
drogram, which is otherwise difficult to do. In this case, the
database was not sufficiently extensive to provide straight-
forward the correct identification due to a complete lack of
data related with C. doubushaemulonii. As a matter of con-
sequence, the culture collections with high quality biologi-
cal materials are key elements to feed the MALDI-TOF MS
databases with reference spectra. In contrast, with this new
approach collections gain the possibility to requalify their
holdings renaming misidentified strains.
MALDI-TOF MS is straightforward, rapid and em-
ploys partially automated procedures. Results are obtained
in approximately 30 sec per sample. Since the time for
pathogen identification is an important determinant of in-
fection-related mortality rates of hospitalised patients, this
technique is an important tool in the fight to reduce mortali-
ties when the time taken for classical methods is consid-
ered.
In summary, the classical phenotypic approaches, in-
cluding VITEK techniques are very important in the daily
routine analyses in health centres and hospitals. However,
it is associated with a high degree of misidentifications
(Lockhart et al., 2008; Marklein et al., 2009; Putignani et
al., 2011) and it would be beneficial for these to be sup-
ported by reference strains provided by culture collections
and, if available, by MALDI-TOF MS with an appropriate
database. MALDI-TOF MS is important to improve the ef-
ficiency of the classical phenotypical methods for clinical
Candida polyphasic identifications even when isolates
where preserved for decades in culture collections.
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